A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 02 Feb 2017
At a glance
- Drugs Placental-derived mesenchymal stem cell therapy Osiris Therapeutics (Primary)
- Indications Diabetic foot ulcer
- Focus Therapeutic Use
- Sponsors Osiris Therapeutics
- 25 Jan 2017 Status changed from recruiting to active, no longer recruiting.
- 06 Oct 2015 Status changed from planning to recruiting according to an Osiris Therapeutics media release.
- 07 Aug 2015 New trial record